| Name | Elementis |
|---|---|
| Epic | ELM |
| Isin | GB0002418548 |
| Index | UK250 UK350 |
| Industry | Chemicals |
| Latest share price | 134.60p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £795.37 | Debt ratio | n/a |
| Shares in issue | 590.58 | Debt-to-equity ratio | n/a |
| P/E ratio | 14.5 | Assets / equity ratio | n/a |
| Total dividends per share | 2.10¢ | Price to book value | n/a |
| Dividend yield | 1.3 | ROCE | 8.12 |
| Dividend cover | 5.24 | EPS growth | -1 |
| Earning per share | 4.8 | 52-week high / low | 117.60p / 166.20p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| Final | 2024-05-02 | 2024-05-31 | 2.10¢ |
| Interim | 2019-09-05 | 2019-09-27 | 2.80¢ |
| Company name | Elementis |
|---|---|
| Address | The Bindery, 5th Floor, 51-53 Hatton Garden London, United Kingdom, EC1N 8HN |
| Telephone | +44 (0)20 7067 2999 |
| Website | http://www.elementis.com/ |
| Director | Position |
|---|---|
| Mr Paul Waterman | CEO |
| Mr Clement Woon | Non-Executive Director |
| Mr Heejae Chae | Non-Executive Director |
| Ms Maria Ciliberti | Non-Executive Director |
| Mr John O'Higgins | Non-Executive Chairman |
| Dr. Trudy Schoolenberg | Senior Independent Director |
| Mrs Dorothee Deuring | Independent Non-Executive Director |
| Ms Christine Soden | Independent Non-Executive Director |
| Mr Ralph Hewins | Group CFO |
| Assets $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 31/12/23 | 31/12/22 | 31/12/21 |
| Intangible asssets and goodwill | 650.6 | 660.2 | 815.7 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 1161.9 | 1116.6 | 1419.7 |
| Inventory / work in progress | 163.3 | 182 | 186.1 |
| Trade and other receivables | 101.8 | 94.9 | 138.9 |
| Cash and equivalents | 65.8 | 54.9 | 84.6 |
| Other current assets and asset held for resale | 18.6 | 17.7 | 7.3 |
| Total of all assets | 1511.4 | 1627 | 1836.6 |
| Liabilities $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 158.9 | 173.5 | 194.9 |
| Long term liabilities | 505.2 | 611.8 | 740.7 |
| Other liabilites / pension etc | n/a | 57.8 | n/a |
| Total of all liabilities | 664.1 | 843.1 | 935.6 |
| Net assets $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 847.3 | 783.9 | 901 |
| Equity $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 52.5 | 52.3 | 52.2 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | 485.5 | 450.8 | 517.3 |
| Share premium account | 239.2 | 238.7 | 240.8 |
| Total equity | 847.3 | 783.9 | 901 |
| Income $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | 58.9 | -41.8 | 11.9 |
| Pre-tax profit | 39.7 | -54.8 | -7.5 |